CH619217A5 - - Google Patents

Download PDF

Info

Publication number
CH619217A5
CH619217A5 CH46176A CH46176A CH619217A5 CH 619217 A5 CH619217 A5 CH 619217A5 CH 46176 A CH46176 A CH 46176A CH 46176 A CH46176 A CH 46176A CH 619217 A5 CH619217 A5 CH 619217A5
Authority
CH
Switzerland
Prior art keywords
cinnarizine
acid
salts
cholesterol
chlorophenoxy
Prior art date
Application number
CH46176A
Other languages
German (de)
English (en)
Inventor
Gunter Dr Metz
Manfred Dr Specker
Original Assignee
Merckle Kg Chem Pharm L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle Kg Chem Pharm L filed Critical Merckle Kg Chem Pharm L
Publication of CH619217A5 publication Critical patent/CH619217A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C07C59/70—Ethers of hydroxy-acetic acid, e.g. substitutes on the ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH46176A 1975-01-23 1976-01-15 CH619217A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2502679A DE2502679C3 (de) 1975-01-23 1975-01-23 Phenoxyalkancarbonsäurederivate, Verfahren zu ihrer Herstellung und Arzneimittel

Publications (1)

Publication Number Publication Date
CH619217A5 true CH619217A5 (fr) 1980-09-15

Family

ID=5937122

Family Applications (1)

Application Number Title Priority Date Filing Date
CH46176A CH619217A5 (fr) 1975-01-23 1976-01-15

Country Status (10)

Country Link
US (1) US4008324A (fr)
AT (1) AT349476B (fr)
BE (1) BE837117A (fr)
CA (1) CA1066280A (fr)
CH (1) CH619217A5 (fr)
DE (1) DE2502679C3 (fr)
FR (1) FR2298323A1 (fr)
GB (1) GB1479419A (fr)
NL (1) NL179813C (fr)
SE (1) SE423629B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61161272A (ja) * 1985-01-11 1986-07-21 Kanebo Ltd 新規なピペラジン誘導体および該化合物を有効成分とする医薬組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2882271A (en) * 1959-04-14 Xcixcxh
GB1051527A (fr) * 1964-07-31
DE1912941C3 (de) * 1969-03-14 1980-06-26 Basf Ag, 6700 Ludwigshafen 1 -Phenyl^-amino-e-methoxypyridaziniumsalze
US3773939A (en) * 1971-11-24 1973-11-20 Janssen Pharmaceutica Nv N-arallyl-n'-aralkyl piperazine pharmaceutical compositions

Also Published As

Publication number Publication date
CA1066280A (fr) 1979-11-13
SE7600670L (sv) 1976-07-24
DE2502679B2 (de) 1980-08-07
FR2298323A1 (fr) 1976-08-20
FR2298323B1 (fr) 1980-05-09
AT349476B (de) 1979-04-10
DE2502679C3 (de) 1981-07-23
NL179813C (nl) 1986-11-17
GB1479419A (en) 1977-07-13
ATA3376A (de) 1978-09-15
NL7600068A (nl) 1976-07-27
US4008324A (en) 1977-02-15
DE2502679A1 (de) 1976-07-29
BE837117A (fr) 1976-04-16
SE423629B (sv) 1982-05-17

Similar Documents

Publication Publication Date Title
DE69110561T2 (de) Mittel zur Behandlung und Vorbeugung von Bauchentzündungen, die als Wirkstoff Zink-L-Carnosin-Salze oder -Komplexe enthalten.
EP0013376A2 (fr) Dérivé d'isoxazole, procédé pour sa préparation et composition le contenant
EP0011237A1 (fr) Dérivés de polyéthers, procédé pour leur préparation et leur application comme médicaments
DE2822789C2 (de) N-Acetyl-DL-methionin-(p-acetylaminophenyl)-ester, Verfahren zu seiner Herstellung und seine Verwendung
DE69620691T2 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
DE3000139C2 (de) Verwendung von Glyzerinphosphorylderivaten zur Behandlung der Dislipämie, der akuten, subakuten oder chronischen Hepatitis und der Steatose
DE2252637C3 (de) Verwendung von 1,3-Glycerindiäthern
DE3026054A1 (de) 4,5-disubstituierte 2-(3,4,5- trimethoxyphenyl)-thiazole und dieselben enthaltendes mittel
DE1932389C3 (fr)
CH631446A5 (de) Verfahren zur herstellung von neuen n-(benzoylmercaptoacyl)-histidinen und n-(mercaptoacyl)-histidinen.
DE69023045T2 (de) Carboxamidderivate.
DE2350148A1 (de) Thiophenderivate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
DE2238280A1 (de) Furanderivate enthaltende arzneimittel und neue n-furoylmorpholinverbindungen
CH655243A5 (de) Arzneimittelkombination und verfahren zu ihrer herstellung.
DE1900772C3 (de) Salz aus N,N-Dimethylbiguanid und p-Chlorphenoxyessigsäure sowie dieses enthaltende Arzneimittel
DE2502679C3 (de) Phenoxyalkancarbonsäurederivate, Verfahren zu ihrer Herstellung und Arzneimittel
DE2038836C3 (de) Arzneimittel
DE2625053B2 (de) Arzneimittel zur Kontrolle von Leberkrankheiten
DE2038628B2 (de) N,N'-Di(carboxyalkyl)-p-phenylendiamine, deren Salze und Diäthylester, Verfahren zu ihrer Herstellung und ihre Verwendung
DE2621873C3 (de) Arzneimittel zur Behandlung von Hypercholesterinämien
DE3026053A1 (de) 2-substituierte-4-thiazolidone
DE2520483A1 (de) Phenoxy-isobuttersaeurederivate und diese verbindungen enthaltende arzneimittel
DE2535799B2 (de) N'- [1 -(p-Chlorbenzoyl)-5-methoxy-2-methyl-3indolyl-acetoxy- alkyl] -N-(N-benzoyl- N',N'-di-npropyl-DL-isoglutaminyloxy- alkyl)-piperazine und diese enthaltene Entzündungen und Gelenksaffektionen hemmende Präparate
DE2502678C3 (de) Arzneimittel zur Behandlung primärer und sekundärer Hyperlipoproteinämien
DE2329819C3 (de) S-Substituierte-L-Cysteine und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased